Baird analyst David Rescott raised the firm’s price target on Axonics to $70 from $67 and keeps an Outperform rating on the shares. The firm reinstaed a Bullish Fresh Pick on Axonics as they continue to see upside to their 2024 and 2025 revenue and profit estimates on now higher numbers, after the company again beat CNS estimates, and delivered its second quarter in a row of positive adjusted net income.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AXNX: